Leishmaniasis Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 66 pages | ID: L34FCE25172FEN
Market Monitor Global

Abstracts

A drug used to treat diseases caused by parasitic protozoa leishmania

This report contains market size and forecasts of Leishmaniasis Treatment in Global, including the following market information:

Global Leishmaniasis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Leishmaniasis Treatment market was valued at 97.9 million in 2021 and is projected to reach US$ 135.8 million by 2028, at a CAGR of 4.8% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Meglumine Antimoniate Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Leishmaniasis Treatment include Merck, iCo Therapeutics, AEterna Zentaris, AEterna Zentaris AG, Eurofins Advinus, Pieris Pharmaceuticals and Dafra Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Leishmaniasis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Leishmaniasis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Leishmaniasis Treatment Market Segment Percentages, by Type, 2021 (%)

• Meglumine Antimoniate
• Pentamidine
• Hydroxyl Amidine Stilbene
• Amphotericin B

Global Leishmaniasis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Leishmaniasis Treatment Market Segment Percentages, by Application, 2021 (%)

• Visceral Leishmaniasis
• Cutaneous Leishmaniasis

Global Leishmaniasis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Leishmaniasis Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Leishmaniasis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Leishmaniasis Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck
• iCo Therapeutics
• AEterna Zentaris
• AEterna Zentaris AG
• Eurofins Advinus
• Pieris Pharmaceuticals
• Dafra Pharma

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Leishmaniasis Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Leishmaniasis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LEISHMANIASIS TREATMENT OVERALL MARKET SIZE

2.1 Global Leishmaniasis Treatment Market Size: 2021 VS 2028
2.2 Global Leishmaniasis Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Leishmaniasis Treatment Players in Global Market
3.2 Top Global Leishmaniasis Treatment Companies Ranked by Revenue
3.3 Global Leishmaniasis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Leishmaniasis Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Leishmaniasis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Leishmaniasis Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Leishmaniasis Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Leishmaniasis Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Leishmaniasis Treatment Market Size Markets, 2021 & 2028
  4.1.2 Meglumine Antimoniate
  4.1.3 Pentamidine
  4.1.4 Hydroxyl Amidine Stilbene
  4.1.5 Amphotericin B
4.2 By Type - Global Leishmaniasis Treatment Revenue & Forecasts
  4.2.1 By Type - Global Leishmaniasis Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Leishmaniasis Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Leishmaniasis Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Leishmaniasis Treatment Market Size, 2021 & 2028
  5.1.2 Visceral Leishmaniasis
  5.1.3 Cutaneous Leishmaniasis
5.2 By Application - Global Leishmaniasis Treatment Revenue & Forecasts
  5.2.1 By Application - Global Leishmaniasis Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Leishmaniasis Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Leishmaniasis Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Leishmaniasis Treatment Market Size, 2021 & 2028
6.2 By Region - Global Leishmaniasis Treatment Revenue & Forecasts
  6.2.1 By Region - Global Leishmaniasis Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Leishmaniasis Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Leishmaniasis Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Leishmaniasis Treatment Revenue, 2017-2028
  6.3.2 US Leishmaniasis Treatment Market Size, 2017-2028
  6.3.3 Canada Leishmaniasis Treatment Market Size, 2017-2028
  6.3.4 Mexico Leishmaniasis Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Leishmaniasis Treatment Revenue, 2017-2028
  6.4.2 Germany Leishmaniasis Treatment Market Size, 2017-2028
  6.4.3 France Leishmaniasis Treatment Market Size, 2017-2028
  6.4.4 U.K. Leishmaniasis Treatment Market Size, 2017-2028
  6.4.5 Italy Leishmaniasis Treatment Market Size, 2017-2028
  6.4.6 Russia Leishmaniasis Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Leishmaniasis Treatment Market Size, 2017-2028
  6.4.8 Benelux Leishmaniasis Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Leishmaniasis Treatment Revenue, 2017-2028
  6.5.2 China Leishmaniasis Treatment Market Size, 2017-2028
  6.5.3 Japan Leishmaniasis Treatment Market Size, 2017-2028
  6.5.4 South Korea Leishmaniasis Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Leishmaniasis Treatment Market Size, 2017-2028
  6.5.6 India Leishmaniasis Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Leishmaniasis Treatment Revenue, 2017-2028
  6.6.2 Brazil Leishmaniasis Treatment Market Size, 2017-2028
  6.6.3 Argentina Leishmaniasis Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Leishmaniasis Treatment Revenue, 2017-2028
  6.7.2 Turkey Leishmaniasis Treatment Market Size, 2017-2028
  6.7.3 Israel Leishmaniasis Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Leishmaniasis Treatment Market Size, 2017-2028
  6.7.5 UAE Leishmaniasis Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Merck
  7.1.1 Merck Corporate Summary
  7.1.2 Merck Business Overview
  7.1.3 Merck Leishmaniasis Treatment Major Product Offerings
  7.1.4 Merck Leishmaniasis Treatment Revenue in Global Market (2017-2022)
  7.1.5 Merck Key News
7.2 iCo Therapeutics
  7.2.1 iCo Therapeutics Corporate Summary
  7.2.2 iCo Therapeutics Business Overview
  7.2.3 iCo Therapeutics Leishmaniasis Treatment Major Product Offerings
  7.2.4 iCo Therapeutics Leishmaniasis Treatment Revenue in Global Market (2017-2022)
  7.2.5 iCo Therapeutics Key News
7.3 AEterna Zentaris
  7.3.1 AEterna Zentaris Corporate Summary
  7.3.2 AEterna Zentaris Business Overview
  7.3.3 AEterna Zentaris Leishmaniasis Treatment Major Product Offerings
  7.3.4 AEterna Zentaris Leishmaniasis Treatment Revenue in Global Market (2017-2022)
  7.3.5 AEterna Zentaris Key News
7.4 AEterna Zentaris AG
  7.4.1 AEterna Zentaris AG Corporate Summary
  7.4.2 AEterna Zentaris AG Business Overview
  7.4.3 AEterna Zentaris AG Leishmaniasis Treatment Major Product Offerings
  7.4.4 AEterna Zentaris AG Leishmaniasis Treatment Revenue in Global Market (2017-2022)
  7.4.5 AEterna Zentaris AG Key News
7.5 Eurofins Advinus
  7.5.1 Eurofins Advinus Corporate Summary
  7.5.2 Eurofins Advinus Business Overview
  7.5.3 Eurofins Advinus Leishmaniasis Treatment Major Product Offerings
  7.5.4 Eurofins Advinus Leishmaniasis Treatment Revenue in Global Market (2017-2022)
  7.5.5 Eurofins Advinus Key News
7.6 Pieris Pharmaceuticals
  7.6.1 Pieris Pharmaceuticals Corporate Summary
  7.6.2 Pieris Pharmaceuticals Business Overview
  7.6.3 Pieris Pharmaceuticals Leishmaniasis Treatment Major Product Offerings
  7.6.4 Pieris Pharmaceuticals Leishmaniasis Treatment Revenue in Global Market (2017-2022)
  7.6.5 Pieris Pharmaceuticals Key News
7.7 Dafra Pharma
  7.7.1 Dafra Pharma Corporate Summary
  7.7.2 Dafra Pharma Business Overview
  7.7.3 Dafra Pharma Leishmaniasis Treatment Major Product Offerings
  7.7.4 Dafra Pharma Leishmaniasis Treatment Revenue in Global Market (2017-2022)
  7.7.5 Dafra Pharma Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Leishmaniasis Treatment Market Opportunities & Trends in Global Market
Table 2. Leishmaniasis Treatment Market Drivers in Global Market
Table 3. Leishmaniasis Treatment Market Restraints in Global Market
Table 4. Key Players of Leishmaniasis Treatment in Global Market
Table 5. Top Leishmaniasis Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Leishmaniasis Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Leishmaniasis Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Leishmaniasis Treatment Product Type
Table 9. List of Global Tier 1 Leishmaniasis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Leishmaniasis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Leishmaniasis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Leishmaniasis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Leishmaniasis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Leishmaniasis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Leishmaniasis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Leishmaniasis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Leishmaniasis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Leishmaniasis Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Leishmaniasis Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Leishmaniasis Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Leishmaniasis Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Leishmaniasis Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Leishmaniasis Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Leishmaniasis Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Leishmaniasis Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Leishmaniasis Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Leishmaniasis Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Leishmaniasis Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Leishmaniasis Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Merck Corporate Summary
Table 31. Merck Leishmaniasis Treatment Product Offerings
Table 32. Merck Leishmaniasis Treatment Revenue (US$, Mn), (2017-2022)
Table 33. iCo Therapeutics Corporate Summary
Table 34. iCo Therapeutics Leishmaniasis Treatment Product Offerings
Table 35. iCo Therapeutics Leishmaniasis Treatment Revenue (US$, Mn), (2017-2022)
Table 36. AEterna Zentaris Corporate Summary
Table 37. AEterna Zentaris Leishmaniasis Treatment Product Offerings
Table 38. AEterna Zentaris Leishmaniasis Treatment Revenue (US$, Mn), (2017-2022)
Table 39. AEterna Zentaris AG Corporate Summary
Table 40. AEterna Zentaris AG Leishmaniasis Treatment Product Offerings
Table 41. AEterna Zentaris AG Leishmaniasis Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Eurofins Advinus Corporate Summary
Table 43. Eurofins Advinus Leishmaniasis Treatment Product Offerings
Table 44. Eurofins Advinus Leishmaniasis Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Pieris Pharmaceuticals Corporate Summary
Table 46. Pieris Pharmaceuticals Leishmaniasis Treatment Product Offerings
Table 47. Pieris Pharmaceuticals Leishmaniasis Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Dafra Pharma Corporate Summary
Table 49. Dafra Pharma Leishmaniasis Treatment Product Offerings
Table 50. Dafra Pharma Leishmaniasis Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Leishmaniasis Treatment Segment by Type in 2021
Figure 2. Leishmaniasis Treatment Segment by Application in 2021
Figure 3. Global Leishmaniasis Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Leishmaniasis Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Leishmaniasis Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Leishmaniasis Treatment Revenue in 2021
Figure 8. By Type - Global Leishmaniasis Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Leishmaniasis Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Leishmaniasis Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Leishmaniasis Treatment Revenue Market Share, 2017-2028
Figure 12. US Leishmaniasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Leishmaniasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Leishmaniasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Leishmaniasis Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Leishmaniasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Leishmaniasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Leishmaniasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Leishmaniasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Leishmaniasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Leishmaniasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Leishmaniasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Leishmaniasis Treatment Revenue Market Share, 2017-2028
Figure 24. China Leishmaniasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Leishmaniasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Leishmaniasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Leishmaniasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Leishmaniasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Leishmaniasis Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Leishmaniasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Leishmaniasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Leishmaniasis Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Leishmaniasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Leishmaniasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Leishmaniasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Leishmaniasis Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Merck Leishmaniasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. iCo Therapeutics Leishmaniasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. AEterna Zentaris Leishmaniasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. AEterna Zentaris AG Leishmaniasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Eurofins Advinus Leishmaniasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pieris Pharmaceuticals Leishmaniasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Dafra Pharma Leishmaniasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)